English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAndrew E. Place, MD, PhD, has been named as Vice President, Pediatric Chief Medical Officer (CMO) at Dana-Farber Cancer Institute (within the Department of Pediatric Oncology) and Boston Children’s Hospital (within the Division of Hematology/Oncology) for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Tag: Oncology
Aster Insights Announces AACR Schedule of ORIEN Presentations
Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced its schedule of research presentations at the American Association for Cancer Research (AACR) annual meeting in San Diego, California, April 5-10, 2024.
Medical and Psycho-Oncologists Available for Interviews
If you are seeking an expert to discuss chemotherapy and coping with potential side effects following a cancer diagnosis, Dr. Mikkael Sekeres is available. We also have available psycho-oncologists who can discuss the psychosocial aspects of dealing with the shock…
Dr. Nima Sharifi Pens JAMA Commentary on Prostate Cancer Variant His Team Identified
Desai Sethi Urology Institute (DSUI) Scientific Director Nima Sharifi, M.D., authored an invited commentary in JAMA Network Open related to a new Million Veteran Program study on the HSD3B1 genotype, an allele he helped discover more than 10 years ago.
Cedars-Sinai Launches Singapore Office
In its latest global expansion, Cedars-Sinai International announced the opening of its new global office in Singapore.
NCCN Updates Treatment Recommendations for Breast, Colorectal, Lung, and other Cancer Types Based on Emerging Evidence
Recent NCCN Guidelines updates—along with the supporting evidence—will be presented during the NCCN 2024 Annual Conference held in Orlando, Florida April 5-7, and simultaneously online. Visit NCCN.org/conference to learn more and register.
Five Signs of Colorectal Cancer You Shouldn’t Ignore – Even if You’re a Younger Adult
The recent Cancer Facts & Figures 2024 report from American Cancer Society (ACS) researchers revealed a stark increase in colorectal cancer (CRC) incidence among Americans under the age of 55. In just two decades, CRC has moved up from being the fourth leading cause of cancer death in both younger men and women, to first in men and second in women.
Dana-Farber and Gustave Roussy to hold third Transatlantic Exchange: Annual scientific conference dedicated to advancing Oncology research and practice
Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the third Transatlantic Exchange in Oncology Conference will address: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine.The meeting, supported by L’Institut Servier, will be held in-person (witha virtual attendance option) on April 12, 2024, at the Revere Hotel Boston Common and livestreamed virtually on Medscape’s platform.
People With Incarceration History Less Likely to Receive Health Care, Including Cancer Screening in the U.S.
A new study led by researchers at the American Cancer Society (ACS) shows people with an incarceration history had worse access to and receipt of healthcare, including physical exams, blood pressure, blood sugar and cholesterol tests, as well as dental check-ups and breast and colorectal cancer screenings compared with people without incarceration history in the United States. The findings are published today in the Journal of the American Medical Association (JAMA) Health Forum.
A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer
Results of 16-Center REVIVE trial published in The New England Journal of Medicine
Medical experts available for March: Colorectal Cancer Awareness, safe sleep & SIDS, returning to sports after injury, sleep aids, and habits to avoid for your brain health
As you plan healthcare coverage for March, Ochsner Health has experts on standby to cover several topics. Are younger people getting colorectal cancer?: Colorectal cancer has always been a cause for concern among middle-aged and older men and women. However,…
New Research Shows Patients with Cancer who Suffered a Major Adverse Financial Event More Likely to be Diagnosed With Advanced Stage Disease
New findings led by researchers at the American Cancer Society and the National Cancer Institute show more than one-third of cancer patients had a major adverse financial event – bankruptcy, lien, or eviction – before their cancer diagnosis.
Director of Oncology Services Northern Region Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
George Raptis, MD, MBA, begins role at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health as director of Oncology Services for the Northern Region of New Jersey.
Expert Analysis: Black Americans Have Highest Cancer Mortality Rates In The United States
For Black History Month, Hackensack Meridian Health offers experts on some of the reasons behind higher cancer rates in the Black community and how to reverse the trends.
Show Your Heart Love for American Heart Month — Johns Hopkins Medicine Adult and Pediatric Experts Available to Discuss Heart Health
February is American Heart Month, a time for awareness of heart-related conditions that affect adults and children. Johns Hopkins Medicine experts are available all month to discuss various aspects of heart health.
Breast cancer test may make bad chemotherapy recommendations for Black patients
Test may underestimate the benefit of chemotherapy for Black women, especially those who are young
American Cancer Society Updates Lung Cancer Screening Guideline: Nearly Five Million U.S. Adults who Smoke and Formerly Smoked Now Recommended for Testing
The American Cancer Society releasesan update of its lung cancer screening guideline to help reduce the number of people dying from the disease due to smoking history.
New Study Shows Insurance Coverage Disruptions Affect Key Cancer Screenings for U.S. Adults
A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.
New Study Shows Adults Treated for Non-Small Cell Lung Cancer Vulnerable to Hazards of Wildfires
New research by scientists at the American Cancer Society and the University of California, San Francisco, shows individuals in the United States undergoing radiotherapy for non-small cell lung cancer who are exposed to wildfires near the treating facility have worse overall survival than unexposed individuals.
New Study Finds Limited Documentation of Cost Discussions With Patients Newly Diagnosed With Advanced Cancer
A new study by researchers at the American Cancer Society and the National Cancer Institute, shows only about a quarter of individuals newly diagnosed with advanced cancers had documented physician discussions about costs of care, which may hinder identifying patient needs and tracking outcomes of referrals for assistance.
New Research Shows Patients Receiving Cancer Treatment Understand Health Insurance Basics; Important Knowledge Gaps Remain
A new study by researchers at the American Cancer Society showed among patients receiving outpatient cancer treatment in two sites, most people could understand basic health insurance terms, such as premiums and deductibles.
Inflammatory Breast Cancer: Know the Risks and Warning Signs of This Rare, Fast-Growing Cancer
Inflammatory breast cancer is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. For October, during Breast Cancer Awareness Month, the American Cancer Society is highlighting IBC to help women be aware of this invasive cancer.
Internationally Recognized Thoracic Oncologist Dr. Taofeek K. Owonikoko Named Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, and University of Maryland Medical Center (UMMC) President and CEO Bert W. O’Malley, MD, announced today that Taofeek K. Owonikoko, MD, PhD, a distinguished physician-scientist with a global reputation in thoracic oncology, has been appointed Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).
Study uncovers function of mysterious disordered regions of proteins implicated in cancer
IDRs comprise a large percentage of the human proteome and are particularly important for nuclear proteins that govern our genomic architecture and gene expression.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting
Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present new, novel, and expansive radiation oncology data from their clinical research program at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting, to be held in San Diego from October 1-4.
New Yale Cancer Center Research Highlighted at Top Radiology Conference
Yale Cancer Center physicians, scientists, and trainees from Yale School of Medicine present new findings at the 65th annual American Society for Radiation Oncology (ASTRO) meeting from October 1-4 in San Diego, Calif.
With Regular Screening, More Women Survive Breast Cancer
To mark Breast Cancer Awareness Month, the American Cancer Society highlights its guidelines encouraging average-risk women to begin regular screening mammograms at age 45, with the option to begin screening as early as age 40.
Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients
Spain is the first country in the world to have this technology
• Results showing the clinical utility of the test were published in
Lancet Oncology and the Journal of National Cancer Institute
• The test is now available to oncologists and pathologists and will
benefit an estimated 24,000 patients each year in Spain
Patients at JFK University Medical Center to Benefit from $1 Million Gift from the Sarala Bathena Foundation
A $1 million gift to Hackensack Meridian JFK University Medical Center Foundation by the Sarala Bathena Foundation will establish the Sarala Bathena Oncology Patient Assistance Fund at Hackensack Meridian JFK University Medical Center, a not-for-profit medical center located in Edison, NJ.
Childhood Cancer Awareness Month Has Special Meaning for Johns Hopkins Children’s Center Pediatric Oncology Nurse
For the past three years, nurse Lauren Chelenza has cared for hundreds of children with cancer while working on the pediatric oncology inpatient unit at Johns Hopkins Children’s Center in Baltimore. It’s a place she never imagined she’d be working 15 years ago, while going through her own cancer treatment.
How Can I Reduce My Risk of Gynecological Cancer in 2023?
The American Cancer Society estimates about 115,000 women will be diagnosed with a gynecologic cancer this year. That’s one case about every five minutes. These types of malignancies originate in the female reproductive organs, most commonly the cervix, endometrium or ovaries. This…
Colorectal Cancer Patients in Sub-Saharan Africa Receiving Inadequate Care; Survival After Diagnosis Poor, New Study Shows
In new findings led by researchers at the American Cancer Society, Martin-Luther University in Germany, and many other institutes worldwide, fewer than one in 20 patients diagnosed with potentially curable colorectal cancer received standard of care in Sub-Saharan Africa.
UChicago Medicine acquires 4 oncology centers in Northwest Indiana
Michiana Hematology Oncology centers in Chesterton, Crown Point, Hobart and Valparaiso have become part of UChicago Medicine’s growing clinical network.
Expert Addresses Stigma, Disparities in Prostate Cancer
David M. Golombos, MD, addresses prostate cancer topics
LJI scientists harness ‘helper’ T cells to treat tumors
La Jolla Institute for Immunology (LJI) scientists have published a pair of studies that show how we might harness CD4+ T cells while boosting the cancer-fighting power of CD8+ “killer” T cells.
September is Prostate Cancer Awareness Month: Know the Warning Signs, When to Get Screened and Important New Treatments
Renowned prostate cancer researcher Dr. Lorelei Mucci is the director of strategic research partnerships at the American Cancer Society. Her role includes leading an ACS initiative called IMPACT, or “Improving Mortality Toward Prostate Cancer Together” to address the alarming negative trends in prostate cancer incidence and disparities. For Prostate Cancer Awareness Month Dr. Mucci reviews the signs and symptoms of prostate cancer, including important information about risk factors, PSA screening, and more.
CureMD Announces Strategic Collaboration with Tempus to Integrate Genomic Testing Functionality in EHR
CureMD, a leading provider of comprehensive technology solutions for community oncology, is proud to announce its partnership with Tempus, a leader in artificial intelligence and precision medicine, to integrate Tempus’ advanced genomic testing capabilities into CureMD’s cutting-edge Electronic Health Record (EHR) system.
Hackensack Meridian Neuroscience Institute Set To Debut First-In-The-World ZAP-X Gyroscopic Radiosurgery® For The Brain Combined With Synaptive MRI To Shorten The Time From Diagnosis To Treatment
New first in the world Zap-X Gyroscopic radiosurgery equipment paired with brain only Synaptive MRI for treatment of brain tumors and other conditions
Common Cold Virus Linked to Potentially Fatal Blood Clotting Disorder
The new observation, made by UNC School of Medicine’s Stephan Moll, MD, and Jacquelyn Baskin-Miller, MD, suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients.
Drinking alcohol not likely to increase risk of a breast cancer recurrence
A Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer survivors: Is it safe to drink alcohol?
Robust analysis challenges theory that depression and anxiety increase cancer risk
Depression and anxiety are thought to increase a person’s risk of developing cancer, but research results have been inconclusive.
New Study Shows Substantial Racial and Ethnic Disparities Among Survivors of Second Primary Cancers in the United States
In new findings from researchers at the American Cancer Society, non-Hispanic Black individuals diagnosed with a second primary cancer experienced 21% higher cancer-related death rates and 41% higher cardiovascular-related death rates compared with their non-Hispanic White counterparts.
MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets
MD Anderson and Nexo announced a strategic research collaboration to rapidly advance new cancer therapies against previously undruggable targets.
New Study Shows Black Cancer Survivors Face Increased Mortality From Heart Disease; Neighborhood Socioeconomic Status and Insurance Contributing Factors
A new study from researchers at the American Cancer Society found that Black cancer survivors in the United States experience a higher risk of dying from cardiovascular disease compared with White cancer survivors.
Cancer Research Institute Awards Over $28 Million in Grants to Fuel Immunotherapy Innovations
The Cancer Research Institute awarded $28.7 million in research grants and fellowships in the 2023 fiscal year ending June 30, 2023. In total, CRI distributed 73 awards that will advance cancer immunology research at 41 institutions in 10 countries. CRI grants were awarded to support projects involving a variety of immune-based approaches as well as the development of novel technologies that may help pave the way for the next generation of immunotherapies.
Study Offers Guidance for Improving Access to Oncology Drug Treatments in Sub-Saharan Africa
Botswana-Rutgers Partnership for Health researchers review treatments that could improve outcomes for patients in a region where cancer rates are rising significantly.
New Study Shows Medicaid Expansion Associated With Increase in Palliative Care for Patients With Advanced Cancers
More people with advanced cancers in the United States received critical palliative care services, according to new findings by researchers at the American Cancer Society. Medicaid expansion under the ACA was associated with the largest increases in palliative care use.
Mental illness obstructs cancer screening
A new study from Aarhus University shows that far too many people with psychological challenges do not accept offers of colorectal cancer screening.
Hackensack Meridian Health Foundation Raises More Than $5 Million at Annual Network Celebration
Hackensack Meridian Health Foundation Raises More Than $5 Million at Annual Network Celebration
Cancer Experts at Jersey Shore University Medical Center Implanting First Targeted Liver Tumor Treatment Pumps in Patients
A team of surgical experts led by Gregory J. Tiesi, M.D., FACS, FSSO, began implanting hepatic artery infusion pumps in patients at Hackensack Meridian Jersey Shore University Medical Center in June. They are among the first in New Jersey to provide the pump for patients.